Stoneridge (SRI) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts SRI Hot Sheet
Price: $6.92 --0%
Financial Fact:
Net loss attributable to noncontrolling interest: -303K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net loss attributable to noncontrolling interest: -303K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Stoneridge (NYSE: SRI) reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $166.8 million versus the consensus estimate of $171.46 million.
For earnings history and earnings-related data on Stoneridge (SRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
- Morgan Stanley comments on Japanese chemical firms posting strong quarterly results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
